BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance.

Abstract:

:This study showed that silencing BMP4 expression significantly activated caspase-2, 3, and 9, while decreasing Matrigel colony formation in Cytarabine (Ara-C)-treated leukemia HL-60 cells. In contrast, Ara-C significantly upregulated Atg5 and Beclin-1 expression, the ratio of LC3-II/LC3-I, and CDK1 and cyclin B1 expression in leukemia cells expressing BMP4. BafA significantly sensitized the apoptotic effect of Ara-C in leukemia cells. Injection of Ara-C significantly inhibited tumor growth in mice inoculated with leukemia cells with BMP4 silenced. In conclusion, BMP4 plays a crucial role in the chemoresistance of leukemia cells through the activation of autophagy and subsequent inhibition of apoptosis.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Zhao X,Liu J,Peng M,Liu J,Chen F

doi

10.3109/07357907.2013.834925

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

555-62

issue

8

eissn

0735-7907

issn

1532-4192

journal_volume

31

pub_type

杂志文章
  • Telomere biology of pediatric cancer.

    abstract::One of the hallmarks of cancer is limitless proliferative capacity, which is tightly associated with the ability to maintain telomeres. Over the last decade, the telomere biology of pediatric cancers has begun to be elucidated. Most pediatric leukemias and embryonal solid tumors activate the enzyme telomerase, a speci...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701208683

    authors: Tabori U,Dome JS

    更新日期:2007-04-01 00:00:00

  • Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.

    abstract::One hundred twenty-two early-stage anal canal cancer patients (median age: 69 years) were treated with curative radiotherapy with (70 patients) or without (52 patients) concomitant chemotherapy. Median follow-up was 65 months (range: 4-238). At multivariate analysis, concomitant chemotherapy significantly improved loc...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001898

    authors: De Bari B,Lestrade L,Pommier P,Maddalo M,Buglione M,Magrini SM,Carrie C

    更新日期:2015-04-01 00:00:00

  • Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.

    abstract::The purpose of this study was to clarify the mechanism of IFN-α resistance in RCC. The effects of IFN-α on induction of apoptosis and cell-cycle arrest were analyzed by flow cytometric analysis. Jak-Stat pathway components induced by IFN-α was evaluated using Western blotting. The results suggested that IFN-α caused g...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568566

    authors: Shang D,Yang P,Liu Y,Song J,Zhang F,Tian Y

    更新日期:2011-06-01 00:00:00

  • Experimental basis for cancer prevention by vitamin E.

    abstract::Recent clinical trials have demonstrated the significant cancer preventive potential of vitamin E in many different cancer sites, ranging from oral and pharyngeal cancer to prostate cancer. There is an extensive experimental basis for this clinical cancer inhibition. The experimental background includes animal studies...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009031826

    authors: Shklar G,Oh SK

    更新日期:2000-01-01 00:00:00

  • Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.

    abstract::There is no known effective salvage chemotherapy for patients with refractory or relapsed urothelial tumors after methotrexate/cisplatin-based regimen. We report the results of a phase II trial with the FIFO regimen that includes from day 1 to 5: fluorouracil 350 mg/m2, folinic acid 20 mg/m2, and ifosfamide 1000 mg/m2...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509094462

    authors: Kattan J,Culine S,Theodore C,Droz JP

    更新日期:1995-01-01 00:00:00

  • High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.

    abstract::Ubiquitin ligase Cullin7 has been has been suggested to act as an oncogene in some tumors; however, the prognostic role of Cullin7 has not been evaluated in cancer patients. In this study, we observed that the expression of Cullin7 mRNA was significantly higher in epithelial ovarian cancer (EOC) compared with normal o...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2015.1114123

    authors: Xi J,Zeng ST,Guo L,Feng J

    更新日期:2016-01-01 00:00:00

  • Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

    abstract::Seven patients developed a lung abscess and bronchopleural fistula after undergoing aggressive treatment of their lung cancer with radiotherapy +/- chemotherapy. These complications were preceded by a prodrome of recurrent bronchitis with increasing refractoriness to antibiotics, weight loss, fever, and generalized de...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077041

    authors: Frytak S,Lee RE,Pairolero PC,Arnold PG,Shaw JN

    更新日期:1988-01-01 00:00:00

  • Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.

    abstract:PURPOSE:Human chondrosarcomas are generally resistant to conventional treatments like chemotherapy and radiotherapy. We investigated the effects of BIBR1532, an inhibitor of telomerase on chondrosarcoma cells in vitro. METHODS:Telomerase activity, telomere lengths, growth kinetics and chemosensitivity were analyzed in...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802072905

    authors: Parsch D,Brassat U,Brümmendorf TH,Fellenberg J

    更新日期:2008-07-01 00:00:00

  • The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth.

    abstract::Tissues become more rigid during tumorigenesis and have been identified as a driving factor for tumor growth. Here, we highlight the concept of tissue rigidity, contributing factors that increase tissue rigidity, and mechanisms that promote tumor growth initiated by increased tissue rigidity. Various factors lead to i...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2020.1802474

    authors: Zakaria MA,Rajab NF,Chua EW,Selvarajah GT,Masre SF

    更新日期:2020-09-01 00:00:00

  • Regression of skin recurrences of breast carcinomas treated with intralesional injections of natural interferons alpha and gamma.

    abstract::Two groups of patients with disseminated breast carcinomas who had failed radiotherapy, chemotherapy, and hormonotherapy were treated with natural interferon alpha (nIFN-alpha) alone or in combination with nIFN-gamma delivered in cycles of 10-12 intralesional (i.l.) injections to recurrent and metastatic lesions. In g...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509011686

    authors: Habif DV,Ozzello L,De Rosa CM,Cantell K,Lattes R

    更新日期:1995-01-01 00:00:00

  • Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.

    abstract::Malignant kidney tumors account for approximately 2% of all new primary cancer cases diagnosed in the United States, with an estimated 30,000 cases occurring annually. Although a variety of agents, chemical and biological, have been implicated as causal agents in the development of renal cell carcinoma (RCC), the etio...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200055962

    authors: Moore LE,Wilson RT,Campleman SL

    更新日期:2005-01-01 00:00:00

  • Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells.

    abstract::Data have shown that tamoxifen (TAM) can be used to treat not only breast cancer with positive estrogen receptor (ER), but also negative ER including human glioma. However, the molecular mechanism of this drug against different kinds of cancers remains to be elucidated. In this study, we provided the evidence that PKC...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802672720

    authors: Tian F,Wu H,Li Z,Wang N,Huang J,Li C,Xie F

    更新日期:2009-08-01 00:00:00

  • IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.

    abstract::Type-I insulin-like growth factor receptor (IGF1R) and its signaling play an important role in osteosarcomagenesis, tumor progression, and chemoresistance. The purpose of this study was to investigate both the effect and mechanisms of IGF1R inhibition by tyrphostin AG1024 in the presence or absence of doxorubicin in a...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.606252

    authors: Luk F,Yu Y,Walsh WR,Yang JL

    更新日期:2011-10-01 00:00:00

  • Phase II trial of paclitaxel in patients with soft-tissue sarcoma.

    abstract::The response rate (RR) to single-agent chemotherapy with doxorubicin or ifosfamide in patients with advanced soft-tissue sarcoma (STS) is in the range of 20%. Paclitaxel is clinically useful in treating several solid tumors and has demonstrated activity in a series of human sarcoma cell lines. Twenty-eight patients wi...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909809011697

    authors: Casper ES,Waltzman RJ,Schwartz GK,Sugarman A,Pfister D,Ilson D,Woodruff J,Leung D,Bertino JR

    更新日期:1998-01-01 00:00:00

  • Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

    abstract::Serum C-reactive protein (CRP), a sensitive marker of systemic inflammation, has been reported to be associated with the risk of a number of cancers including breast cancer. However, the results are inconsistent. To investigate the association between serum CRP levels and early breast cancer, we conducted a hospital-b...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.789898

    authors: Hong T,Liu A,Cai D,Zhang Y,Hua D,Hang X,Wu X

    更新日期:2013-05-01 00:00:00

  • A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.

    abstract::A randomized trial was conducted comparing ketoconazole and nystatin in the prevention of oral candidiasis and appearance of invasive fungal infections in 51 neutropenic leukemic patients undergoing induction chemotherapy. Ketoconazole was administered in a 200 mg dose twice daily. Nystatin oral suspension was given i...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Vogler WR,Malcom LG,Winton EF

    更新日期:1987-01-01 00:00:00

  • A Pilot Study of Side Effects of Cancer Therapies and their Impact on Satisfaction with Life.

    abstract::This survey aimed at getting a first insight into diverse side effects and their association with satisfaction with life as well as the use of complementary and alternative medicine (CAM) in cancer patients. A total of 100 patients in a German University Hospital were included. General side effects like fatigue, fever...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1625055

    authors: Kroker L,Dubois C,Münstedt K,Büntzel J,Keinki C,Hübner J

    更新日期:2019-01-01 00:00:00

  • Chromosome breaks and genomic instability.

    abstract::Tumorigenesis is known to result from multiple genetic changes. Although endogenous and environmental insults can damage DNA, cellular mechanisms exist to repair various forms of damage or to kill those cells irreparably damaged. Hence, the accumulation of numerous genetic changes that would lead to cancer in normal c...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009023065

    authors: Jasin M

    更新日期:2000-01-01 00:00:00

  • 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.

    abstract::A phase II trial of 5-fluorouracil (5-FU) [250-450 mg/m2/day x 5 days as an intravenous (IV) bolus] combined with calcium leucovorin (500 mg/m2/day x 5 1/2 days by continuous IV infusion) administered on a 28-day schedule was performed in 15 patients with advanced hepatocellular carcinoma. The median age was 58 years;...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509024907

    authors: Tetef M,Doroshow J,Akman S,Coluzzi P,Leong L,Margolin K,Morgan RJ Jr,Raschko J,Shibata S,Somlo G

    更新日期:1995-01-01 00:00:00

  • Managing patients and families at the ending of life: hospice assumptions, structures, and practice in response to staff stress.

    abstract::Hospice programs do not identify burnout as a significant staff problem, even though there are many significant stressors for staff members doing hospice work. Hospices offer support in a wide variety of ways and settings through their human resources management. All this support is predicated on the assumption that t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709039724

    authors: Brenner PR

    更新日期:1997-01-01 00:00:00

  • The effect of castration on the synthesis and secretion of proteins in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

    abstract:UNLABELLED:The effect of castration on the incorporation of [35S]methionine into secreted proteins in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors, was investigated. Biopsy specimens were obtained from 19 tumors, 0, 24, 48, 72, and 96 h after castration. In 14 tumors, castration induced an increase ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209032762

    authors: Geier A,Hemi R,Beery R,Lunenfeld B

    更新日期:1992-01-01 00:00:00

  • Corticosteroids in cancer: neuropsychiatric complications.

    abstract::The addition of corticosteroids in the early 1950s to the treatment armamentarium provided cure of some diseases and control of many. They have become an integral part of many cancer treatment regimens. Early reports of severe affective disorders appear less frequent today in patients receiving steroids, though contro...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908909041378

    authors: Stiefel FC,Breitbart WS,Holland JC

    更新日期:1989-01-01 00:00:00

  • 5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung.

    abstract::Thirty patients with a diagnosis of metastatic adenocarcinoma of the lung were entered on a trial to evaluate the antitumor efficacy of 5-fluorouracil 370 mg/m2 daily for 5 days every four weeks in combination with folinic acid 200 mg/m2, 60 min prior to 5FU. All patients had a good performance status, bidimensionally...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909009012052

    authors: Evans WK,Wierzbicki R,Shepherd FA,Rusthoven J,Stewart DJ,Aitken SE,Maroun JA,Ezzat A

    更新日期:1990-01-01 00:00:00

  • Clinical cancer research, DNR orders, and medical economics: a complex interrelationship.

    abstract::Despite the dramatic success achieved over the past few years in improving the survival of individuals with cancer, treatment for many patients with advanced malignancies remains far from satisfactory. Unfortunately, centers engaged in clinical cancer research are currently faced with the dilemma of dealing with incre...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357908709011740

    authors: Markman M

    更新日期:1987-01-01 00:00:00

  • Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.

    abstract::Tumor-infiltrating leukocytes and other immunohistochemical parameters were evaluated in pretherapeutic biopsies and resection specimens in 73 patients undergoing neoadjuvant chemotherapy with doxorubicin and paclitaxel. Ten patients with pathological complete response had significantly higher p53 expression, CD3(+) l...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802098165

    authors: Hornychova H,Melichar B,Tomsova M,Mergancova J,Urminska H,Ryska A

    更新日期:2008-12-01 00:00:00

  • A Review of Quality of Life Measures used in Surgical Outcomes for Stage I Lung Cancers.

    abstract::This review summarizes the literature on QoL in early stage lung cancer patients who underwent surgery. PubMed and PsycINFO were searched. Twelve articles from 10 distinct studies were identified for a total of 992 patients. Five QoL measures were used. One study reported only on pre-surgical QoL, six only on post-sur...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1474892

    authors: Yip R,Taioli E,Schwartz R,Li K,Becker BJ,Tam K,Htwe YM,Yankelevitz DF,Henschke CI

    更新日期:2018-01-01 00:00:00

  • Leukemic stem cells: a review.

    abstract::A small subset of cells in a patient with leukemia, termed leukemic stem cells (LSCs) have been shown to be responsible for the proliferation of disease. LSCs are thought to derive from normal hematopoietic stem cells, but are phenotypically distinguishable in that they are CD90(-), CD117(-), and CD123(+). Research in...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.700986

    authors: O'Brien JA,Rizzieri DA

    更新日期:2013-05-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Human interleukin 2 gene is located on chromosome 4.

    abstract::The interleukin-2 (IL2) gene is assigned to human chromosome 4. A synthetic oligonucleotide representing bases 285 to 324 of the IL2 cDNA clone described by Taniguchi et al. [Nature (London) 302:305-310, 1983] was used as hybridization probe in Southern blots. Eco RI digests of DNA derived from 11 somatic mouse-human ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908409018440

    authors: Sykora KW,Kolitz J,Szabo P,Grzeschik KH,Moore MA,Mertelsmann R

    更新日期:1984-01-01 00:00:00

  • Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma.

    abstract::The results of a prospective trial with a specifically devised chemotherapy regimen in elderly patients with unfavorable non-Hodgkin's lymphoma (NHL) are reported. Between April 1983 and April 1986, 37 consecutive patients 70 years old or more (median age 80) received etoposide and prednimustine (E + P) 100 mg/m2 p.o....

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909009018923

    authors: Zagonel V,Tirelli U,Carbone A,Errante D,Morassot S,Sorio R,Monfardini S

    更新日期:1990-01-01 00:00:00